Iron therapy effect on fatigue in palliative cancer patients.
Not Applicable
Completed
- Conditions
- Health Condition 1: C800- Disseminated malignant neoplasm, unspecified
- Registration Number
- CTRI/2021/06/034095
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 63
Inclusion Criteria
1) Patients of age group 18 and 80 years of either sex.
2) Performance status of 0â??3 on the (ECOG performance status) scale.
3) Metastatic non myeloid cancer patient not on any curative /palliative chemotherapy or radiation therapy.
4) Hemoglobin ranging from 8gm/dl to 12 gm/dl in women and 8gm/dl to 13 gm/dl in Men (as per WHO Definition).
Exclusion Criteria
1) Age below 18 years.
2) Patients with blood transfusion in the last one month.
3) Patients receiving active therapy or had completed chemotherapy/radiation one month back.
4) Presence of dementia, agitation, or delirium or mental disorder.
5) Terminally ill patients with PS greater than 3.
6) Hemoglobin < 8gm% (Severe Anaemia).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the Role of IV iron therapy on fatigue and quality of life in patients of palliative care. <br/ ><br>Timepoint: Baseline ,1 week ,1 month <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1.Assessing the Symptom burden of Fatigue in palliative care. <br/ ><br>2.Prevalence of fatigue in patients on palliative care. <br/ ><br>Timepoint: At baseline